Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion type Assertion NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_head.
- NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion description "[Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_provenance.
- NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion evidence source_evidence_literature NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_provenance.
- NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion SIO_000772 22665066 NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_provenance.
- NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion wasDerivedFrom befree-2016 NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_provenance.
- NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_assertion wasGeneratedBy ECO_0000203 NP987142.RASjcHsr60oN_FR0Rp5D3beVE3TVNtaA1PDwv-G56pf0w130_provenance.